Item 8.01 Other Events.

On September 10, 2021, Adagio Therapeutics, Inc. (the "Company") issued a press release entitled "Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19." The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



              Exhibit
                No.     Description

              99.1        Press release, dated September 10, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses